Ensartinib trials for Lung cancer

All Ensartinib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Ensartinib for Lung cancer

• A Real World Study of Ensartinib in Advanced ALK-positive NSCLC
  NCT05498064 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer
  NCT05241028 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer
  NCT05341583 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.
  NCT06563999 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Ensartinib for Lung cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.